Role of Nitric Oxide in Matrix Remodeling in Diabetes and Heart Failure

Overview

Journal Heart Fail Rev

Date 2003 Mar 26

PMID 12652156

Citations 12

Authors

Suresh C Tyagi

Melvin R Hayden

Affiliations

Soon will be listed here.

Abstract

Accumulation of oxidized-matrix between the endothelium and myocytes is associated with endocardial endothelial (EE) dysfunction in diabetes and heart failure. High levels of circulating homocysteine (Hcy) have been demonstrated in diabetes mellitus (DM). These high levels of Hcy (hyperhomocysteinemia, HHcy) have a negative correlation with peroxisome proliferator activated receptor (PPAR) expression. Studies have demonstrated that Hcy decreases bioavailability of endothelial nitric oxide (eNO), generates nitrotyrosine, and activates latent matrix metalloproteinase (MMP), instigating EE dysfunction. PPAR ligands ameliorate endothelial dysfunction and DM. In addition Hcy competes with PPAR ligands. The understanding of molecular, cellular, and extracellular mechanisms by which Hcy amplifies DM will have therapeutic ramifications for diabetic cardiomyopathy.

Citing Articles

Role of estrogen in diastolic dysfunction.

Zhao Z, Wang H, Jessup J, Lindsey S, Chappell M, Groban L Am J Physiol Heart Circ Physiol. 2014; 306(5):H628-40.

PMID: 24414072 PMC: 3949059. DOI: 10.1152/ajpheart.00859.2013.

Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.

Santos J, Tewari S, Lin J, Kowluru R Biochem Biophys Res Commun. 2013; 438(4):760-4.

PMID: 23891690 PMC: 3864795. DOI: 10.1016/j.bbrc.2013.07.066.

Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and Intima.

Hayden M, Habibi J, Joginpally T, Karuparthi P, Sowers J Cardiorenal Med. 2012; 2(1):66-82.

PMID: 22493605 PMC: 3318941. DOI: 10.1159/000335565.

An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation.

Nadeau M, Georges R, Laforest B, Yamak A, Lefebvre C, Beauregard J Proc Natl Acad Sci U S A. 2010; 107(45):19356-61.

PMID: 20974940 PMC: 2984205. DOI: 10.1073/pnas.0914888107.

Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.

Kowluru R Invest Ophthalmol Vis Sci. 2010; 51(8):4320-6.

PMID: 20220057 PMC: 2910650. DOI: 10.1167/iovs.09-4851.

References

Lebovitz H, Banerji M . Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res. 2001; 56:265-94. DOI: 10.1210/rp.56.1.265. View

Hackam D, Peterson J, Spence J . What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Am J Hypertens. 2000; 13(1 Pt 1):105-10. DOI: 10.1016/s0895-7061(99)00180-6. View

Thompson E . Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatment. Am J Anat. 1988; 182(3):270-82. DOI: 10.1002/aja.1001820308. View

Yamamoto K, Ohki R, Lee R, Ikeda U, Shimada K . Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation. 2001; 104(14):1670-5. DOI: 10.1161/hc4001.097186. View

Nash D . Insulin resistance, ADMA levels, and cardiovascular disease. JAMA. 2002; 287(11):1451-2. DOI: 10.1001/jama.287.11.1451. View

Taylor D, Atkins B, Hungspreugs P, Jones T, Reedy M, Hutcheson K . Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998; 4(8):929-33. DOI: 10.1038/nm0898-929. View

Davi G, Di Minno G, Coppola A, Andria G, Cerbone A, Madonna P . Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001; 104(10):1124-8. DOI: 10.1161/hc3501.095287. View

Di Bello V, Giampietro O, Matteucci E, Talarico L, Giorgi D, Bertini A . Ultrasonic videodensitometric analysis in type 1 diabetic myocardium. Coron Artery Dis. 1996; 7(12):895-901. DOI: 10.1097/00019501-199612000-00004. View

Radomski A, Sawicki G, Olson D, Radomski M . The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol. 1999; 125(7):1455-62. PMC: 1565728. DOI: 10.1038/sj.bjp.0702216. View

10.

Henderson A, Lewis M, Shah A, Smith J . Endothelium, endocardium, and cardiac contraction. Cardiovasc Res. 1992; 26(4):305-8. DOI: 10.1093/cvr/26.4.305. View

11.

Miller A, Mujumdar V, Palmer L, Bower J, Tyagi S . Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens. 2002; 15(2 Pt 1):157-63. DOI: 10.1016/s0895-7061(01)02286-5. View

12.

Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N . Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000; 101(8):899-907. DOI: 10.1161/01.cir.101.8.899. View

13.

Sokolov E, Zaichikova O, Tsyplenkova V . [Ultrastructure of the myocardium in patients with cardiac pathology complicated by diabetes mellitus]. Arkh Patol. 1998; 60(1):49-54. View

14.

Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M . Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001; 104(3):342-5. DOI: 10.1161/01.cir.104.3.342. View

15.

Kajstura J, Fiordaliso F, Andreoli A, Li B, Chimenti S, Medow M . IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes. 2001; 50(6):1414-24. DOI: 10.2337/diabetes.50.6.1414. View

16.

Rolland P, Friggi A, Barlatier A, Piquet P, Latrille V, Faye M . Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation. 1995; 91(4):1161-74. DOI: 10.1161/01.cir.91.4.1161. View

17.

Drzewoski J, Czupryniak L, Chwatko G, Bald E . Hyperhomocysteinemia in poorly controlled type 2 diabetes patients. Diabetes Nutr Metab. 2001; 13(6):319-24. View

18.

Dierkes J, Westphal S, Luley C . Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999; 354(9174):219-20. DOI: 10.1016/S0140-6736(99)02153-4. View

19.

BLANE G . Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med. 1987; 83(5B):26-36. DOI: 10.1016/0002-9343(87)90868-0. View

20.

Starkebaum G, Harlan J . Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986; 77(4):1370-6. PMC: 424498. DOI: 10.1172/JCI112442. View